Immunohematology -- Case studies : Immunohematology, transfusion medicine, hemostasis, and cellular therapy : a case study approach / Mark T. Friedman [and five others]
Immunoinformatics -- Congresses : Artificial immune systems : 11th International Conference, ICARIS 2012, Taormina, Italy, August 28-31, 2012. Proceedings / Carlos A. Coello Coello [and others] (eds.)
2012
1
Immunoinformatics -- Handbooks, manuals, etc : Handbook of research on artificial immune systems and natural computing : applying complex adaptive technologies / Hongwei Mo, [editor]
Immunologia clínica. : Inflammation, infection, and microbiome in cancers : evidence, mechanisms, and implications / Jun Sun, editor
2021
1
Immunologia de la trasplantació. : Emerging transplant infections : clinical challenges and implications / Michele I. Morris, Camille Nelson Kotton, Cameron R. Wolfe, editors
A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity
The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement
Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID)
